Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Non Lymphoblastic Leukemia
>>
Merck (MSD)
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
MK-2206
/ Merck (MSD)
Intron A
(interferon α-2b) / Merck (MSD), Biogen
Januvia
(sitagliptin) / Merck (MSD)
Koselugo
(selumetinib) / Merck (MSD), AstraZeneca
dinaciclib
(MK-7965) / Merck (MSD)
